Pretreatment resistance to hepatitis C virus protease inhibitors boceprevir/telaprevir in hepatitis C virus subgenotype 1a-infected patients from Manitoba
about
CIHR Canadian HIV Trials Network Co-Infection and Concurrent Diseases Core: Updated Canadian guidelines for the treatment of hepatitis C infection in HIV-hepatitis C coinfected adultsAn update on the management of chronic hepatitis C: 2015 Consensus guidelines from the Canadian Association for the Study of the Liver.Biophysical Studies on HCV 1a NS3/4A Protease and Its Catalytic Triad in Wild Type and Mutants by the In Silico Approach.Worldwide distribution of the NS3 gene 80K polymorphism among circulating hepatitis C genotype 1 viruses: implication for simeprevir usage.
P2860
Pretreatment resistance to hepatitis C virus protease inhibitors boceprevir/telaprevir in hepatitis C virus subgenotype 1a-infected patients from Manitoba
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pretreatment resistance to hep ...... nfected patients from Manitoba
@en
Pretreatment resistance to hep ...... fected patients from Manitoba.
@nl
type
label
Pretreatment resistance to hep ...... nfected patients from Manitoba
@en
Pretreatment resistance to hep ...... fected patients from Manitoba.
@nl
prefLabel
Pretreatment resistance to hep ...... nfected patients from Manitoba
@en
Pretreatment resistance to hep ...... fected patients from Manitoba.
@nl
P2093
P2860
P356
P1476
Pretreatment resistance to hep ...... nfected patients from Manitoba
@en
P2093
Anton Andonov
Carla Osiowy
Kamran Kadkhoda
Kelly Kaita
P2860
P304
P356
10.1155/2013/273856
P407
P577
2013-07-01T00:00:00Z